Literature DB >> 22810271

Resistance-associated epitopes of HIV-1C-highly probable candidates for a multi-epitope vaccine.

Jagadish Chandrabose Sundaramurthi1, Soumya Swaminathan, Luke Elizabeth Hanna.   

Abstract

Earlier studies have identified a large number of immunogenic epitopes in HIV-1. Efforts are required to prioritize these epitopes in order to identify the best candidates for formulating an effective multi-epitope vaccine for HIV. We modeled 155 known cytotoxic T lymphocyte epitopes of HIV-1 subtype C on the 3D structure of HLA-A*0201, HLA-B*2705, and HLA-B*5101 using MODPROPEP, as these alleles are known to be associated with resistance to HIV/slow progression to AIDS. Thirty-six epitopes were identified to bind to all the three HLA alleles with better binding affinity than the control peptides complexed with each HLA allele but not to any of the HLA alleles reported to be associated with susceptibility to HIV infection/rapid progression to disease. As increase in stability of the epitope-HLA complex results in increased immunogenicity, the short-listed epitopes could be suitable candidates for vaccine development. Twenty of the 36 epitopes were polyfunctional in nature adding to their immunological relevance for vaccine design. Further, 9 of the 20 polyfunctional epitopes were found to bind to all three resistance-associated HLA alleles using an additional method, adding worth to their potential as candidates for a vaccine formulation for HIV-1C.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22810271     DOI: 10.1007/s00251-012-0635-z

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  49 in total

1.  Nonstandard peptide binding revealed by crystal structures of HLA-B*5101 complexed with HIV immunodominant epitopes.

Authors:  K Maenaka; T Maenaka; H Tomiyama; M Takiguchi; D I Stuart; E Y Jones
Journal:  J Immunol       Date:  2000-09-15       Impact factor: 5.422

2.  Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection.

Authors:  L Musey; J Hughes; T Schacker; T Shea; L Corey; M J McElrath
Journal:  N Engl J Med       Date:  1997-10-30       Impact factor: 91.245

3.  Association of human leukocyte antigen-A11 with resistance and B40 and DR2 with susceptibility to HIV-1 infection in south India.

Authors:  Paramasivam Selvaraj; Soumya Swaminathan; Kalichamy Alagarasu; Sampathkumar Raghavan; Gopalan Narendran; Paramjir Narayanan
Journal:  J Acquir Immune Defic Syndr       Date:  2006-12-01       Impact factor: 3.731

4.  Impact of HLA-B alleles, epitope binding affinity, functional avidity, and viral coinfection on the immunodominance of virus-specific CTL responses.

Authors:  Florian Bihl; Nicole Frahm; Loriana Di Giammarino; John Sidney; Mina John; Karina Yusim; Tonia Woodberry; Kaori Sango; Hannah S Hewitt; Leah Henry; Caitlyn H Linde; John V Chisholm; Tauheed M Zaman; Eunice Pae; Simon Mallal; Bruce D Walker; Alessandro Sette; Bette T Korber; David Heckerman; Christian Brander
Journal:  J Immunol       Date:  2006-04-01       Impact factor: 5.422

5.  Multilayered defense in HLA-B51-associated HIV viral control.

Authors:  YongHong Zhang; YanChun Peng; HuiPing Yan; Keyi Xu; Masumichi Saito; Hao Wu; XinYue Chen; Srinika Ranasinghe; Nozomi Kuse; Tim Powell; Yan Zhao; WeiHua Li; Xin Zhang; Xia Feng; Ning Li; Aleksandra Leligdowicz; XiaoNing Xu; Mina John; Masafumi Takiguchi; Andrew McMichael; Sarah Rowland-Jones; Tao Dong
Journal:  J Immunol       Date:  2011-06-13       Impact factor: 5.422

6.  The structural basis for the increased immunogenicity of two HIV-reverse transcriptase peptide variant/class I major histocompatibility complexes.

Authors:  T J Kirksey; R R Pogue-Caley; J A Frelinger; E J Collins
Journal:  J Biol Chem       Date:  1999-12-24       Impact factor: 5.157

7.  Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection.

Authors:  P Borrow; H Lewicki; B H Hahn; G M Shaw; M B Oldstone
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

8.  Structures of HLA-A*1101 complexed with immunodominant nonamer and decamer HIV-1 epitopes clearly reveal the presence of a middle, secondary anchor residue.

Authors:  Lenong Li; Marlene Bouvier
Journal:  J Immunol       Date:  2004-05-15       Impact factor: 5.422

9.  SVMHC: a server for prediction of MHC-binding peptides.

Authors:  Pierre Dönnes; Oliver Kohlbacher
Journal:  Nucleic Acids Res       Date:  2006-07-01       Impact factor: 16.971

10.  HLA Alleles Associated with Delayed Progression to AIDS Contribute Strongly to the Initial CD8(+) T Cell Response against HIV-1.

Authors:  Marcus Altfeld; Elizabeth T Kalife; Ying Qi; Hendrik Streeck; Mathias Lichterfeld; Mary N Johnston; Nicole Burgett; Martha E Swartz; Amy Yang; Galit Alter; Xu G Yu; Angela Meier; Juergen K Rockstroh; Todd M Allen; Heiko Jessen; Eric S Rosenberg; Mary Carrington; Bruce D Walker
Journal:  PLoS Med       Date:  2006-10       Impact factor: 11.069

View more
  1 in total

1.  The value of HIV protective epitope research for informed vaccine design against diverse viral pathogens.

Authors:  Victor G Kramer; Siddappa N Byrareddy
Journal:  Expert Rev Vaccines       Date:  2014-06-26       Impact factor: 5.217

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.